Lu-AG-06474
- Generic Name
- Lu-AG-06474
A Trial Investigating the Pain-relieving Properties of Lu AG06474 in Healthy Adult Participants
Phase 1
Completed
- Conditions
- Healthy Participants
- Interventions
- First Posted Date
- 2023-10-11
- Last Posted Date
- 2024-06-28
- Lead Sponsor
- H. Lundbeck A/S
- Target Recruit Count
- 26
- Registration Number
- NCT06077786
- Locations
- 🇳🇱
Centre for Human Drug Research, Leiden, Netherlands
A Study Investigating Lu AG06474 in Healthy Young Participants
- First Posted Date
- 2023-07-13
- Last Posted Date
- 2024-11-18
- Lead Sponsor
- H. Lundbeck A/S
- Target Recruit Count
- 56
- Registration Number
- NCT05943327
- Locations
- 🇺🇸
Quotient Sciences Miami, Miami, Florida, United States
Safety and Tolerability of Lu AG06474 in Healthy Young Men
- First Posted Date
- 2021-08-12
- Last Posted Date
- 2023-01-09
- Lead Sponsor
- H. Lundbeck A/S
- Target Recruit Count
- 79
- Registration Number
- NCT05003687
- Locations
- 🇺🇸
Quotient Sciences Miami, Miami, Florida, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath